Clinical Trial Update: M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis [NA]

View source ↗

Summary

ClinicalTrials.gov update on the M-PART trial evaluating KeraStat Cream for acute radiation dermatitis in head and neck cancer patients; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Dermatitis

Drugs mentioned

• KeraStat Cream

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Radiation Dermatitis | NA | Status: ACTIVE_NOT_RECRUITING